DABRAFENIB MESYLATE
UNII B6DC89I63E

Substance Identification & Data

This profile provides standardized clinical and technical data for Dabrafenib Mesylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B6DC89I63E.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1195768-06-9 and the RxNorm Concept ID (RxCUI) 1425222. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

B6DC89I63E

CAS Registry Number

1195768-06-9

RxNorm Concept ID

1425222

Detailed Substance Profile

Preferred Name

DABRAFENIB MESYLATE

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

B6DC89I63E

The specific atomic composition represented as a molecular structure string.

InChIKey

C23H20F3N5O2S2.CH4O3S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

YKGMKSIHIVVYKY-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C128059

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

44516822

Unique identification number in the NCBI database of chemical substances.

USAN ID

XX-157

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

Nc1nc(ccn1)-c2c(nc(s2)C(C)(C)C)-c3c(c(ccc3)NS(=O)(=O)c4c(cccc4F)F)F.CS(=O)(=O)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dabrafenib Mesylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.